Gut microbiome |
Pubbl/distr/stampa | Cambridge : , : Cambridge University Press in association with The Nutrition Society, , [2020]- |
Descrizione fisica | 1 online resource |
Disciplina | 612.3601579 |
Soggetto topico |
Intestines - Microbiology
Intestines - Diseases Intestins - Microbiologie Intestins - Maladies Gastrointestinal Microbiome Gastrointestinal Diseases - microbiology Gastrointestinal Tract - microbiology Intestins Microbiologia Malalties intestinals |
Soggetto genere / forma |
Periodicals
Periodicals. Periodical Revistes electròniques |
ISSN | 2632-2897 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti |
GutMicrobiome
GMB |
Record Nr. | UNISA-996427047003316 |
Cambridge : , : Cambridge University Press in association with The Nutrition Society, , [2020]- | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
The gut microbiome : implications for human disease / / edited by Gyula Mozsik |
Pubbl/distr/stampa | Rijeka, Croatia : , : IntechOpen, , [2016] |
Descrizione fisica | 1 online resource (112 pages) : illustrations |
Disciplina | 612.33 |
Soggetto topico | Intestines - Microbiology |
ISBN |
953-51-5458-3
953-51-2751-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti |
Gut microbiome
The Gut Microbiome â Implications for Human Disease |
Record Nr. | UNINA-9910317686503321 |
Rijeka, Croatia : , : IntechOpen, , [2016] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Handbook of probiotics and prebiotics [[electronic resource] /] / edited by Yuan Kun Lee, Seppo Salminen |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2009 |
Descrizione fisica | 1 online resource (618 p.) |
Disciplina |
660.62
664.001/579 |
Altri autori (Persone) |
LeeY. K (Yuan Kun)
SalminenSeppo |
Soggetto topico |
Probiotics
Intestines - Microbiology Food - Microbiology Microorganisms - Therapeutic use |
Soggetto genere / forma | Electronic books. |
ISBN |
1-282-03079-5
9786612030796 1-61344-867-8 0-470-43262-4 0-470-43261-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
HANDBOOK OF PROBIOTICS AND PREBIOTICS; CONTENTS; PREFACE; CONTRIBUTORS; PART I PROBIOTICS; 1 Probiotic Microorganisms; 1.1 Definitions; 1.2 Screening, Identification, and Characterization of Lactobacillus and Bifidobacterium Strains; 1.2.1 Sources of Screening for Probiotic Strains; 1.2.2 Identification, Classification, and Typing of Bifidobacterium Strains; 1.2.2.1 Taxonomy; 1.2.2.2 Identification and Typing; 1.2.3 Identification, Classification, and Typing of Lactobacillus Strains; 1.2.3.1 Taxonomy; 1.2.3.2 Identification and Typing
1.2.4 Characterization of Probiotic Properties in Bifidobacterium and Lactobacillus Strains1.2.4.1 Survival to GIT Stressing Conditions; 1.2.4.2 Adhesion/Colonization to/of GIT; 1.2.4.3 Antimicrobial Activity; 1.2.4.4 Other Probiotic Properties; 1.2.5 Conclusion; 1.3 Detection and Enumeration of Gastrointestinal Microorganisms; 1.3.1 Methods for Intestinal Microbiota Assessment; 1.3.1.1 Culture-Dependent Methods; 1.3.1.2 Culture-Independent Methods; 1.3.2 Detection and Enumeration in Dairy Products; 1.3.3 Detection and Enumeration of Specific Probiotics in the Gut 1.3.4 The Problem of the Viability and Physiological State of Intestinal Bacteria1.3.5 Conclusions; 1.4 Enteric Microbial Community Profiling in Gastrointestinal Tract by Terminal-Restriction Fragment Length Polymorphism (T-RFLP); 1.4.1 T-RFLP; 1.4.2 Universal and Group-Specific Primers; 1.4.3 Fluorescent Dyes; 1.4.4 DNA Extraction; 1.4.5 PCR Amplification; 1.4.6 Generation of Terminal Restriction Fragments (TRF) by Digestion of Amplicons with Restriction Enzymes; 1.4.7 Software and Data Processing; 1.4.8 Microbial Diversity in Different Intestinal Compartments of Pigs 1.4.9 Tracking the Fate of Orally Delivered Probiotics in Feces1.4.10 Conclusion; 1.5 Effective Dosage for Probiotic Effects; 1.5.1 Acute (Rotavirus) Diarrhea in Children; 1.5.2 Antibiotic-Associated Diarrhea; 1.5.2.1 Combination of L. acidophilus + bifidobacteria or Streptococcus thermophilus; 1.5.2.2 L. rhamnosus GG or Saccharomyces boulardii Applied Singly; 1.5.3 Helicobacter pyroli; 1.6 Incorporating Probiotics into Foods; 1.6.1 Probiotic Ingredients; 1.6.2 Factors Affecting the Viability of Probiotics in Foods; 1.6.2.1 Choice of Probiotic Organism/Food Combinations 1.6.2.2 Physiologic State of the Probiotic1.6.2.3 Temperature; 1.6.2.4 pH; 1.6.2.5 Water Activity; 1.6.2.6 Oxygen; 1.6.2.7 Toxicity of Ingredients; 1.6.2.8 Growth Factors, Protective, and Synergistic Ingredients; 1.6.2.9 Freeze-Thawing; 1.6.2.10 Sheer Forces; 1.6.3 Synbiotics; 1.6.4 Delivery Systems; 1.6.4.1 Microencapsulation; 1.6.4.2 Delivery Devices; 1.6.5 Probiotic Foods; 1.6.6 Conclusions; 1.7 Safety of Probiotic Organisms; 1.7.1 Current Proposals for Probiotic Safety; 1.7.2 Taxonomic Identification; 1.7.3 Pathogenicity; 1.7.4 Antibiotic Resistance and Susceptibility 1.7.5 Immune Modulation |
Record Nr. | UNINA-9910145956603321 |
Hoboken, NJ, : John Wiley & Sons, c2009 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Handbook of probiotics and prebiotics [[electronic resource] /] / edited by Yuan Kun Lee, Seppo Salminen |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2009 |
Descrizione fisica | 1 online resource (618 p.) |
Disciplina |
660.62
664.001/579 |
Altri autori (Persone) |
LeeY. K (Yuan Kun)
SalminenSeppo |
Soggetto topico |
Probiotics
Intestines - Microbiology Food - Microbiology Microorganisms - Therapeutic use |
ISBN |
1-282-03079-5
9786612030796 1-61344-867-8 0-470-43262-4 0-470-43261-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
HANDBOOK OF PROBIOTICS AND PREBIOTICS; CONTENTS; PREFACE; CONTRIBUTORS; PART I PROBIOTICS; 1 Probiotic Microorganisms; 1.1 Definitions; 1.2 Screening, Identification, and Characterization of Lactobacillus and Bifidobacterium Strains; 1.2.1 Sources of Screening for Probiotic Strains; 1.2.2 Identification, Classification, and Typing of Bifidobacterium Strains; 1.2.2.1 Taxonomy; 1.2.2.2 Identification and Typing; 1.2.3 Identification, Classification, and Typing of Lactobacillus Strains; 1.2.3.1 Taxonomy; 1.2.3.2 Identification and Typing
1.2.4 Characterization of Probiotic Properties in Bifidobacterium and Lactobacillus Strains1.2.4.1 Survival to GIT Stressing Conditions; 1.2.4.2 Adhesion/Colonization to/of GIT; 1.2.4.3 Antimicrobial Activity; 1.2.4.4 Other Probiotic Properties; 1.2.5 Conclusion; 1.3 Detection and Enumeration of Gastrointestinal Microorganisms; 1.3.1 Methods for Intestinal Microbiota Assessment; 1.3.1.1 Culture-Dependent Methods; 1.3.1.2 Culture-Independent Methods; 1.3.2 Detection and Enumeration in Dairy Products; 1.3.3 Detection and Enumeration of Specific Probiotics in the Gut 1.3.4 The Problem of the Viability and Physiological State of Intestinal Bacteria1.3.5 Conclusions; 1.4 Enteric Microbial Community Profiling in Gastrointestinal Tract by Terminal-Restriction Fragment Length Polymorphism (T-RFLP); 1.4.1 T-RFLP; 1.4.2 Universal and Group-Specific Primers; 1.4.3 Fluorescent Dyes; 1.4.4 DNA Extraction; 1.4.5 PCR Amplification; 1.4.6 Generation of Terminal Restriction Fragments (TRF) by Digestion of Amplicons with Restriction Enzymes; 1.4.7 Software and Data Processing; 1.4.8 Microbial Diversity in Different Intestinal Compartments of Pigs 1.4.9 Tracking the Fate of Orally Delivered Probiotics in Feces1.4.10 Conclusion; 1.5 Effective Dosage for Probiotic Effects; 1.5.1 Acute (Rotavirus) Diarrhea in Children; 1.5.2 Antibiotic-Associated Diarrhea; 1.5.2.1 Combination of L. acidophilus + bifidobacteria or Streptococcus thermophilus; 1.5.2.2 L. rhamnosus GG or Saccharomyces boulardii Applied Singly; 1.5.3 Helicobacter pyroli; 1.6 Incorporating Probiotics into Foods; 1.6.1 Probiotic Ingredients; 1.6.2 Factors Affecting the Viability of Probiotics in Foods; 1.6.2.1 Choice of Probiotic Organism/Food Combinations 1.6.2.2 Physiologic State of the Probiotic1.6.2.3 Temperature; 1.6.2.4 pH; 1.6.2.5 Water Activity; 1.6.2.6 Oxygen; 1.6.2.7 Toxicity of Ingredients; 1.6.2.8 Growth Factors, Protective, and Synergistic Ingredients; 1.6.2.9 Freeze-Thawing; 1.6.2.10 Sheer Forces; 1.6.3 Synbiotics; 1.6.4 Delivery Systems; 1.6.4.1 Microencapsulation; 1.6.4.2 Delivery Devices; 1.6.5 Probiotic Foods; 1.6.6 Conclusions; 1.7 Safety of Probiotic Organisms; 1.7.1 Current Proposals for Probiotic Safety; 1.7.2 Taxonomic Identification; 1.7.3 Pathogenicity; 1.7.4 Antibiotic Resistance and Susceptibility 1.7.5 Immune Modulation |
Record Nr. | UNINA-9910830322803321 |
Hoboken, NJ, : John Wiley & Sons, c2009 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Handbook of probiotics and prebiotics [[electronic resource] /] / edited by Yuan Kun Lee, Seppo Salminen |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2009 |
Descrizione fisica | 1 online resource (618 p.) |
Disciplina |
660.62
664.001/579 |
Altri autori (Persone) |
LeeY. K (Yuan Kun)
SalminenSeppo |
Soggetto topico |
Probiotics
Intestines - Microbiology Food - Microbiology Microorganisms - Therapeutic use |
ISBN |
1-282-03079-5
9786612030796 1-61344-867-8 0-470-43262-4 0-470-43261-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
HANDBOOK OF PROBIOTICS AND PREBIOTICS; CONTENTS; PREFACE; CONTRIBUTORS; PART I PROBIOTICS; 1 Probiotic Microorganisms; 1.1 Definitions; 1.2 Screening, Identification, and Characterization of Lactobacillus and Bifidobacterium Strains; 1.2.1 Sources of Screening for Probiotic Strains; 1.2.2 Identification, Classification, and Typing of Bifidobacterium Strains; 1.2.2.1 Taxonomy; 1.2.2.2 Identification and Typing; 1.2.3 Identification, Classification, and Typing of Lactobacillus Strains; 1.2.3.1 Taxonomy; 1.2.3.2 Identification and Typing
1.2.4 Characterization of Probiotic Properties in Bifidobacterium and Lactobacillus Strains1.2.4.1 Survival to GIT Stressing Conditions; 1.2.4.2 Adhesion/Colonization to/of GIT; 1.2.4.3 Antimicrobial Activity; 1.2.4.4 Other Probiotic Properties; 1.2.5 Conclusion; 1.3 Detection and Enumeration of Gastrointestinal Microorganisms; 1.3.1 Methods for Intestinal Microbiota Assessment; 1.3.1.1 Culture-Dependent Methods; 1.3.1.2 Culture-Independent Methods; 1.3.2 Detection and Enumeration in Dairy Products; 1.3.3 Detection and Enumeration of Specific Probiotics in the Gut 1.3.4 The Problem of the Viability and Physiological State of Intestinal Bacteria1.3.5 Conclusions; 1.4 Enteric Microbial Community Profiling in Gastrointestinal Tract by Terminal-Restriction Fragment Length Polymorphism (T-RFLP); 1.4.1 T-RFLP; 1.4.2 Universal and Group-Specific Primers; 1.4.3 Fluorescent Dyes; 1.4.4 DNA Extraction; 1.4.5 PCR Amplification; 1.4.6 Generation of Terminal Restriction Fragments (TRF) by Digestion of Amplicons with Restriction Enzymes; 1.4.7 Software and Data Processing; 1.4.8 Microbial Diversity in Different Intestinal Compartments of Pigs 1.4.9 Tracking the Fate of Orally Delivered Probiotics in Feces1.4.10 Conclusion; 1.5 Effective Dosage for Probiotic Effects; 1.5.1 Acute (Rotavirus) Diarrhea in Children; 1.5.2 Antibiotic-Associated Diarrhea; 1.5.2.1 Combination of L. acidophilus + bifidobacteria or Streptococcus thermophilus; 1.5.2.2 L. rhamnosus GG or Saccharomyces boulardii Applied Singly; 1.5.3 Helicobacter pyroli; 1.6 Incorporating Probiotics into Foods; 1.6.1 Probiotic Ingredients; 1.6.2 Factors Affecting the Viability of Probiotics in Foods; 1.6.2.1 Choice of Probiotic Organism/Food Combinations 1.6.2.2 Physiologic State of the Probiotic1.6.2.3 Temperature; 1.6.2.4 pH; 1.6.2.5 Water Activity; 1.6.2.6 Oxygen; 1.6.2.7 Toxicity of Ingredients; 1.6.2.8 Growth Factors, Protective, and Synergistic Ingredients; 1.6.2.9 Freeze-Thawing; 1.6.2.10 Sheer Forces; 1.6.3 Synbiotics; 1.6.4 Delivery Systems; 1.6.4.1 Microencapsulation; 1.6.4.2 Delivery Devices; 1.6.5 Probiotic Foods; 1.6.6 Conclusions; 1.7 Safety of Probiotic Organisms; 1.7.1 Current Proposals for Probiotic Safety; 1.7.2 Taxonomic Identification; 1.7.3 Pathogenicity; 1.7.4 Antibiotic Resistance and Susceptibility 1.7.5 Immune Modulation |
Record Nr. | UNINA-9910840714103321 |
Hoboken, NJ, : John Wiley & Sons, c2009 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health and the gut : the emerging role of intestinal microbiota in disease and therapeutics / / edited by William Olds |
Pubbl/distr/stampa | Toronto : , : Apple Academic Press |
Descrizione fisica | 1 online resource (402 p.) : illustrations |
Disciplina | 612.3/3 |
Soggetto topico |
Intestines - Microbiology
Intestines - Diseases |
ISBN |
1-77463-204-7
0-429-18343-7 1-4987-0126-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; About the Editor; Contents; Acknowledgment and How to Cite; List of Contributors; Introduction; Part I: Introduction: The Rainforest in the Gut; Chapter 1: Nutrition, Microbiomes, and Intestinal Inflammation; Part II: Microbiome's Role in Obesity; Chapter 2: Gut Microbiota: In Sickness and in Health; Chapter 3: Microbial Reprogramming Inhibits Western Diet-Associated Obesity; Chapter 4: Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice
Chapter 5: Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced ObesityChapter 6: Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in Diet-Induced Obese Mice is Associated with Gut Microbial Changes and Reduction in Obesity; Part III: Inflammation and Innate Immunity; Chapter 7: Antimicrobial Peptides and Gut Microbiota in Homeostasis and Pathology; Chapter 8: Matrix Metalloproteinase 13 Modulates Intestinal Epithelial Barrier Integrity in Inflammatory Diseases by Activating TNF Part IV: Nutrition's Effect on the MicrobiomeChapter 9: Impact of a Synbiotic Food on the Gut Microbial Ecology and Metabolic Profiles; Chapter 10: Diet-Microbiota Interactions and their Implications for Healthy Living; Part V: Using the Microbiome to Identify and Cure Disease; Chapter 11: Prebiotics, Faecal Transplants and Microbial Network Units to Stimulate Biodiversity of the Human Gut Microbiome; Chapter 12: Microbiota and Healthy Aging: Observational and Nutritional Intervention Studies Chapter 13: Gut Pharmacomicrobiomics: The Tip of an Iceberg of Complex Interactions between Drugs and Gut-Associated MicrobesChapter 14: Fame and Future of Fecal Transplantations: Developing Next-Generation Therapies with Synthetic Microbiomes; Author Notes; Back Cover |
Record Nr. | UNINA-9910787961403321 |
Toronto : , : Apple Academic Press | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Health and the gut : the emerging role of intestinal microbiota in disease and therapeutics / / edited by William Olds |
Pubbl/distr/stampa | Toronto : , : Apple Academic Press |
Descrizione fisica | 1 online resource (402 p.) : illustrations |
Disciplina | 612.3/3 |
Soggetto topico |
Intestines - Microbiology
Intestines - Diseases |
ISBN |
1-77463-204-7
0-429-18343-7 1-4987-0126-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; About the Editor; Contents; Acknowledgment and How to Cite; List of Contributors; Introduction; Part I: Introduction: The Rainforest in the Gut; Chapter 1: Nutrition, Microbiomes, and Intestinal Inflammation; Part II: Microbiome's Role in Obesity; Chapter 2: Gut Microbiota: In Sickness and in Health; Chapter 3: Microbial Reprogramming Inhibits Western Diet-Associated Obesity; Chapter 4: Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice
Chapter 5: Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced ObesityChapter 6: Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in Diet-Induced Obese Mice is Associated with Gut Microbial Changes and Reduction in Obesity; Part III: Inflammation and Innate Immunity; Chapter 7: Antimicrobial Peptides and Gut Microbiota in Homeostasis and Pathology; Chapter 8: Matrix Metalloproteinase 13 Modulates Intestinal Epithelial Barrier Integrity in Inflammatory Diseases by Activating TNF Part IV: Nutrition's Effect on the MicrobiomeChapter 9: Impact of a Synbiotic Food on the Gut Microbial Ecology and Metabolic Profiles; Chapter 10: Diet-Microbiota Interactions and their Implications for Healthy Living; Part V: Using the Microbiome to Identify and Cure Disease; Chapter 11: Prebiotics, Faecal Transplants and Microbial Network Units to Stimulate Biodiversity of the Human Gut Microbiome; Chapter 12: Microbiota and Healthy Aging: Observational and Nutritional Intervention Studies Chapter 13: Gut Pharmacomicrobiomics: The Tip of an Iceberg of Complex Interactions between Drugs and Gut-Associated MicrobesChapter 14: Fame and Future of Fecal Transplantations: Developing Next-Generation Therapies with Synthetic Microbiomes; Author Notes; Back Cover |
Record Nr. | UNINA-9910806146603321 |
Toronto : , : Apple Academic Press | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Intestinal microbiota in health and disease : modern concepts / / editors, Eduardo J. Schiffrin, Medical Director, Nestle Research Centre, Lausanne, Switzerland, Philippe Marteau, Professor, Department Medico-Chirurgical de Pathologie Digestive |
Pubbl/distr/stampa | Boca Raton : , : CRC Press, , [2014] |
Descrizione fisica | 1 online resource (345 p.) |
Disciplina | 612.33 |
Soggetto topico |
Intestines - Microbiology
Intestines - Diseases |
ISBN |
0-429-17232-X
1-4822-2677-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Front Cover ""; ""Preface ""; ""Contents ""; ""Chapter 1: Commensal Intestinal Microbiota And Mucosal Immune System Development And Function ""; ""Chapter 2: Presentation Of Microbial Signals Via Maternal Cells An Evolutionary Advantage Of Mammals ""; ""Chapter 3: Interactions Of The Intestinal Microbiota With Mucosal Epithelial Cells ""; ""Chapter 4: Pathogen-Host Cell Interactions At The Intestinal Level: Lessons From Cultured Human Fully-Differentiated Colon Cancer Caco-2 And T84 Epithelial Cell Lines ""; ""Chapter 5: Manipulation Of The Host-Cell Pathways By Bacterial Enteropathogens ""
""Chapter 6: The Role Of Probiotics In Prevention And Treatment Of Gi Infections """"Chapter 7: The Microbiota In Inflammatory Bowel Disease ""; ""Chapter 8: Opportunistic Pathogens In Inflammatory Bowel Disease, And The Relation With Specific Gene Susceptibilities ""; ""Chapter 9: Opportunistic Pathogens In Inflammatory Bowel Disease, The Case Of Adherent-Invasivee. Coli ""; ""Chapter 10: Correction Of Microbiota Disturbances Or Antagonism Against Specific Pathogens In Ibd "" ""Chapter 11: Probiotics In Inflammatory Bowel Disease: Modulation Of The Pathological Immune Or Inflammatory Activation: Their Potential Benefits In The Different Phases Of The Disease """"Chapter 12: Mechanisms, Prevention And Management Of Diarrhoea In Enteral Nutrition ""; ""Chapter 13: Influence Of The Intestinal Microbiota On The Critically Ill Patient ""; ""Chapter 14: Gut Microbiota In Obesity And Type-2 Diabetes: Links With Diet And Weight Loss Intervention ""; ""Color Plate Section ""; ""Back Cover "" |
Record Nr. | UNINA-9910789004403321 |
Boca Raton : , : CRC Press, , [2014] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Intestinal microbiota in health and disease : modern concepts / / editors, Eduardo J. Schiffrin, Medical Director, Nestle Research Centre, Lausanne, Switzerland, Philippe Marteau, Professor, Department Medico-Chirurgical de Pathologie Digestive |
Pubbl/distr/stampa | Boca Raton : , : CRC Press, , [2014] |
Descrizione fisica | 1 online resource (345 p.) |
Disciplina | 612.33 |
Soggetto topico |
Intestines - Microbiology
Intestines - Diseases |
ISBN |
0-429-17232-X
1-4822-2677-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Front Cover ""; ""Preface ""; ""Contents ""; ""Chapter 1: Commensal Intestinal Microbiota And Mucosal Immune System Development And Function ""; ""Chapter 2: Presentation Of Microbial Signals Via Maternal Cells An Evolutionary Advantage Of Mammals ""; ""Chapter 3: Interactions Of The Intestinal Microbiota With Mucosal Epithelial Cells ""; ""Chapter 4: Pathogen-Host Cell Interactions At The Intestinal Level: Lessons From Cultured Human Fully-Differentiated Colon Cancer Caco-2 And T84 Epithelial Cell Lines ""; ""Chapter 5: Manipulation Of The Host-Cell Pathways By Bacterial Enteropathogens ""
""Chapter 6: The Role Of Probiotics In Prevention And Treatment Of Gi Infections """"Chapter 7: The Microbiota In Inflammatory Bowel Disease ""; ""Chapter 8: Opportunistic Pathogens In Inflammatory Bowel Disease, And The Relation With Specific Gene Susceptibilities ""; ""Chapter 9: Opportunistic Pathogens In Inflammatory Bowel Disease, The Case Of Adherent-Invasivee. Coli ""; ""Chapter 10: Correction Of Microbiota Disturbances Or Antagonism Against Specific Pathogens In Ibd "" ""Chapter 11: Probiotics In Inflammatory Bowel Disease: Modulation Of The Pathological Immune Or Inflammatory Activation: Their Potential Benefits In The Different Phases Of The Disease """"Chapter 12: Mechanisms, Prevention And Management Of Diarrhoea In Enteral Nutrition ""; ""Chapter 13: Influence Of The Intestinal Microbiota On The Critically Ill Patient ""; ""Chapter 14: Gut Microbiota In Obesity And Type-2 Diabetes: Links With Diet And Weight Loss Intervention ""; ""Color Plate Section ""; ""Back Cover "" |
Record Nr. | UNINA-9910815563603321 |
Boca Raton : , : CRC Press, , [2014] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Metabolism of Alimentary Compounds by the Intestinal Microbiota and Health / / François Blachier |
Autore | Blachier François |
Edizione | [First edition.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer Nature Switzerland AG, , [2023] |
Descrizione fisica | 1 online resource (265 pages) |
Disciplina | 615.7 |
Soggetto topico |
Intestines
Intestines - Microbiology |
ISBN |
9783031263224
9783031263217 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Physiological and Metabolic Functions of the Intestinal Epithelium: From the Small to the Large Intestine -- Chapter 2. Intestine Offers Board and Lodging for Intestinal Microbes on a Short- or Long-Term Stay -- Chapter 3. Metabolism of Dietary Substrates by Intestinal Bacteria and Consequences for the Host Intestine -- Chapter 4. Alimentation, Bacterial Metabolites, and Host Intestinal Epithelium -- Chapter 5. Modification of the Bacterial Metabolites by the Host after Absorption, and Consequences for the Peripheral Tissues’ Metabolism, Physiology, and Pathophysiology -- Chapter 6. Lessons to Be Learned from Clinical and Experimental Research on the Intestinal Microbiota Metabolic Activity for Health Benefit and Perspectives. |
Record Nr. | UNINA-9910720075903321 |
Blachier François
![]() |
||
Cham, Switzerland : , : Springer Nature Switzerland AG, , [2023] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|